Stock Market & Financial Investment News

News Breaks March 8, 2013 07:50 EDT CLDX Celldex price target raised to $16 from $13 at Cantor Cantor increased its price target on Celldex as the firm now expects the company to begin obtaining revenues from both CDX-011 and rindopepimut in 2016 versus its original forecast of 2017. The firm maintains a Buy rating on the stock. News For CLDX From The Last 14 Days Check below for free stories on CLDX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 19, 2013 07:38 EDT CLDX Celldex to deliver results in-line with guidance, says Brean Capital Subscribe for More Information June 14, 2013 10:52 EDT CLDX High option volume stocks: CLDX AON KNDI MYGN SPLS June 13, 2013 14:40 EDT CLDX Celldex management to meet with Brean Capital Subscribe for More Information June 12, 2013 11:18 EDT CLDX High option volume stocks: KNDI GPC SE KOG CLDX 07:38 EDT CLDX Celldex price target raised to $19 from $14 at Brean Capital Brean Capital raised its price target on Celldex due to its strong clinical data and robust pipeline. Shares are Buy rated. June 11, 2013 11:54 EDT CLDX Celldex management to meet with Jefferies Subscribe for More Information June 10, 2013 11:18 EDT CLDX High option volume stocks: ORIG SVNT O CLDX SCCO Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.